Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and AIDS Dementia Complex

rosiglitazone has been researched along with AIDS Dementia Complex in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendayan, R; Choi, UY; Hoque, MT; Omeragic, A1
Dou, H; Heilman, D; Knipe, B; Leibhart, J; Mercer, A; Morsey, B; Papugani, A; Persidsky, Y; Potula, R; Ramirez, SH; Schall, K1

Other Studies

2 other study(ies) available for rosiglitazone and AIDS Dementia Complex

ArticleYear
Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Journal of neuroinflammation, 2017, Sep-08, Volume: 14, Issue:1

    Topics: AIDS Dementia Complex; Animals; Encephalitis; HIV-1; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones

2017
Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.
    AIDS (London, England), 2008, Aug-20, Volume: 22, Issue:13

    Topics: AIDS Dementia Complex; Animals; Brain; Cells, Cultured; HIV Long Terminal Repeat; HIV-1; Humans; Macrophages; Mice; Mice, SCID; Models, Animal; NF-kappa B; PPAR gamma; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Viremia; Virus Replication

2008